US Federal 2025-2026 Regular Session

US Federal Senate Bill SB3103

Introduced
11/4/25  

Caption

A bill to authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.

Impact

If enacted, SB3103 would notably impact U.S. foreign trade policy by allowing the President to extend favorable trade terms to more countries while removing restrictive measures from those deemed unworthy under existing trade laws. The bill particularly identifies Belarus, Cuba, and North Korea as countries excluded from receiving nondiscriminatory treatment, signaling a clear stance on international relations with these nations. This could lead to an increase in trade with other countries as economic policies adjust to encourage more open and equitable trade practices.

Summary

Senate Bill 3103 seeks to authorize the extension of nondiscriminatory treatment, also known as normal trade relations treatment, to products from certain countries. The bill aims to amend the Trade Act of 1974, particularly Title IV, which currently imposes restrictions on trade with selected nations. The bill outlines the President's authority to determine which countries will qualify for this treatment, effectively facilitating a more flexible approach to international trade relations based on current political and economic considerations.

Contention

Discussion surrounding SB3103 may bring forth various points of contention. For advocates, the enhancement of trade relations could bolster the U.S. economy by opening up new markets for American goods and services. However, critics may raise concerns regarding the implications of expanding trade relationships without addressing existing human rights or geopolitical issues tied to the countries benefiting from such treatment. The balance between promoting free trade and maintaining stringent foreign policy objectives remains a complex and potentially divisive topic in legislative circles.

Companion Bills

US HB5917

Same As To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.

Previously Filed As

US HB5917

To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.

US HB2329

Uzbekistan Normalized Trade Act

US HB377

Authorizes an individual to refuse certain medical treatments

US HB1024

US-Kazakhstan Trade Modernization Act

US SB3081

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025

US HB1504

China Trade Relations Act of 2025

US HB7521

United States-Cuba Trade Act of 2026

US HB3799

Relating to medical treatments with investigational products.

US HB7091

Expanding Veterans’ Access to Emerging Treatments Act

US AB1949

Medi-Cal: acupuncture treatments.

Similar Bills

No similar bills found.